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min D supplementation can reduce age-related tau hyper-
phosphorylation and cognitive impairment by enhancing
brain energy homeostasis and protein phosphatase 2A
(PP2A) activity, and modulating the redox state. Male F344
rats aged 20 months (aged) and 6 months (young) were ran-
domly assigned to either vitamin D supplementation or no
supplementation (control). Rats were housed in pairs and
the supplementation group (n= 10 young and n= 10 aged)
received subcutaneous injections of vitamin D (1, a25-
dihydroxyvitamin D3) for 21 days. Control animals (n= 10
young and n= 10 aged) received equal volume of normal
saline and behavioral testing in the water maze started on
day 14 after the initiation of vitamin D supplementation.
Tau phosphorylation, markers of brain energy metabolism
(ADP/ATP ratio and adenosine monophosphate-activated
protein kinase) and redox state (levels of reactive oxygen
species, activity of superoxide dismutase, and glutathione
levels) as well as PP2A activity were measured in hippocam-
pal tissues. Our results extended previous ﬁndings that: (1)
tau phosphorylation signiﬁcantly increased during aging;
(2) markers of brain energy metabolism and redox state
are signiﬁcantly decreased in aging; and (3) aged rats dem-
onstrated signiﬁcant learning and memory impairment.
More importantly, we found that age-related changes in
brain energy metabolism, redox state, and cognitive func-
tion were attenuated by vitamin D supplementation. No sig-
niﬁcant diﬀerences were seen in tau hyperphosphorylation,
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REmarkers of energy metabolism and redox state in the young
animal groups. Our data suggest that vitamin D ameliorated
the age-related tau hyperphosphorylation and cognitive
decline by enhancing brain energy metabolism, redox state,
and PP2A activity making it a potentially useful therapeutic
option to alleviate the eﬀects of aging.  2014 The
Authors. Published by Elsevier Ltd. All rights reserved.
Key words: water maze, superoxide dismutase, glutathione,
cognitive aging.
INTRODUCTION
The brain, like most organs, undergoes a gradual decline
in energy metabolism during aging (Navarro and Boveris,
2007; Boveris and Navarro, 2008). Since neurons require
large amounts of energy to carry out their functions such
as ﬁring of action potentials and neurotransmission, they
are vulnerable to the eﬀects of age-related decrease in
energy metabolism. The brain’s source of energy
primarily comes from glucose delivered via oxygen
supply and both of them are diminished during aging as
illustrated in clinical imaging studies that show age-
dependent reduction of glucose utilization in most
human brain regions (reviewed in Shulman et al., 2004).
Similarly, experimental studies in the rat brain show an
age-dependent decrease in oxygen uptake especially in
the hippocampus and cortex (LaFrance et al., 2005;
Navarro et al., 2008), brain regions involved in memory
processing; thus, the decline in energy metabolism
during aging most likely contributes to age-related
cognitive impairment. When neurons fail to adapt to the
age-related decline in basal metabolic rate, they
become susceptible to neurodegenerative disorders
(Atamna and Frey, 2007; Gibson et al., 2010).
The energy-transducing capacity of mitochondria
meets the neuronal energy demands through its most
prominent metabolic process, which is oxidative
phosphorylation (OXPHOS) generating the universal
energy currency, adenosine triphosphate (Yin et al.,
2012a). Free radicals are generated during normal
mitochondrial function of OXPHOS as a result of
electron transfer (Balaban et al., 2005). Steady state
levels of free radicals produced are determined by both
rate of energy metabolism and the integrity of the redox
(oxidation–reduction) systems (Yap et al., 2009; Yin
et al., 2012a). Consequently, the decrease in the
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Dmitochondrial energy-transducing capacity commonly
seen in aging is then associated with a progressive
increase in free radical production. The maintenance of
redox homeostasis becomes crucial for neuronal
function because disruption in energy homeostasis can
shift the cells from a reduced state to an oxidized state
that can predispose neurons to damage, dysfunction,
and death (Yin et al., 2012b). For example, lower
glucose availability in both in vivo and in vitro models
induces hyperphosphorylation of the tau protein
(reviewed in Kapogiannis and Mattson, 2011).
Age-related decrease in levels and activity of protein
phosphatase 2A (PP2A) can also result in increased tau
phosphorylation (Gong et al., 2001). Hyperphosphory-
lation of the tau protein is linked to the formation
of neuroﬁbrillary tangles (Yin et al., 2012a). Because
the presence of neuroﬁbrillary tangles is one of the
pathological hallmarks of Alzheimer’s disease and
associated with cognitive impairment (Kapogiannis and
Mattson, 2011), it stands to reason that decreased brain
energy metabolism and PP2A activity can contribute to
the development of neurodegenerative disorders.
Dietary and/or pharmacologic antioxidants and
hormones are some of the proposed therapies to
combat age-related changes in redox state and
cognitive function. One of the hormones gaining
increasing support as a therapeutic agent to provide
neuroprotection in the aging brain is vitamin D. The
prevalence of chronic low-serum vitamin D
concentration in the elderly is estimated to be 50–80%
(Nesby-O’Dell et al., 2002; Coudray et al., 2005). More
recently, a meta-analysis report shows that vitamin D
concentration is even lower in patients with Alzheimer’s
disease when compared to age-matched controls
(Annweiler et al., 2013). Vitamin D has multiple
biological targets mediated by vitamin D receptors
(VDR) present in most cells including neurons and glial
cells (Eyles et al., 2005) and that the enzyme
responsible for the synthesis of the active form of
vitamin D is ubiquitous in the brain (Eyles et al., 2005;
Kalueﬀ and Tuohimaa, 2007; Buell and Dawson-
Hugues, 2008). In the central nervous system, VDR is
shown to be located in the human cortex and
hippocampus (Eyles et al., 2005), which are key brain
areas involved in cognitive functioning. Studies show
that in the central nervous system, vitamin D is involved
in the regulation of neurotransmission, neuroprotection,
and immunomodulation (Brown et al., 2003; Spach and
Hayes, 2005; Dursun et al., 2010). Hence, in the
present study we examined whether vitamin D
supplementation can reduce age-related tau
phosphorylation and cognitive impairment by enhancing
brain energy metabolism and phosphatase activity, and
modulating the redox state.
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TREXPERIMENTAL PROCEDURES
Subjects
Male F344 rats aged 20 months (aged) and 6 months
(young) obtained from the Harlan Laboratories
(Madison, WI, USA) were used. Rats were housedindividually in a pathogen-free vivarium under controlled
condition (temperature 22 ± 1 C and humidity
70 ± 5%) and a 14:10-h light:dark cycle was
maintained. All animals were housed in the same room
so that temperature, humidity, and lighting conditions
are similar for all groups. Animals had free access to
food (Harlan Tekland 8604 rodent chow containing
24.3% crude protein, 2.4 IU/g vitamin D3, 1.4% calcium,
and 1.1% phosphorus, and 14% calories of fat) and
water. Animals were also handled daily throughout the
study so that they could get acclimated to the research
personnel thereby decreasing stress. Experiments
started two weeks after arrival of the animals and all
experimental protocols in this study were approved by
the Institutional Animal Care and Use Committee and in
accordance with the National Institutes of Health
guidelines.Vitamin D supplementation
Two weeks after arrival from the breeder, young and aged
rats were randomly assigned to either control (CON) or
vitamin D supplementation (vitamin D) group (Fig. 1). A
total of n= 40 rats were used in the study (n= 10
animals in each young and aged CON groups; n= 10
animals in each young and aged vitamin D groups). The
supplementation group received the active metabolite of
vitamin D (1, a25-dihydroxyvitamin D3; Calbiochem, La
Jolla, CA, USA) 42 IU/kg based on our previous work
(Briones and Darwish, 2012) where this amount of
vitamin D and the duration of supplementation produced
an elevation of serum levels without any other side
eﬀects (e.g. lethargy, weight loss, diarrhea). Vitamin D
was prepared daily and dissolved in 1% alcohol (diluted
with sterile saline). Injections instead of dietary or water
supplementation were chosen to be able to control the
amount of vitamin D given because each animal’s
dietary and water intake is variable. Rats in the CON
group received 99% normal saline and 1% alcohol of
equal volume to control for the eﬀects of stress induced
by the injection. Both vitamin D and normal saline
injections were given subcutaneously daily for a total of
21 days and rats were weighed once a week during the
supplementation regimen and no group diﬀerences were
seen. Rats were also monitored daily for possible side
eﬀects (n= 0) such as apathy, lethargy, and diarrhea.
TEBehavioral testing
Two weeks after vitamin D or saline injections started,
rats were tested in the water maze to evaluate cognitive
impairment. All testing were done approximately 2 h
prior to the onset of the dark cycle to ensure that it is
close to the rats’ active period. Behavioral testing was
performed in the water maze for both spatial (cued-
learning and memory) and non-spatial (discrimination
learning) tasks. Rats were given a habituation swim and
consistent water temperature was maintained
throughout the test days to minimize animal stress
during behavioral testing. The habituation training was
given the day before actual testing for the purpose of
teaching the rats to swim and locate the platform using
Fig. 1. Timeline. Study timeline. Legend: D – day.
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Athe visible cue and also to rule out visual impairments and
mobility problems. The habituation training consisted of
four trials where a white wooden block (diﬀerent cue
from the one used in the actual testing) was attached to
a visible platform and this cue remained in a ﬁxed
location and the starting location was also ﬁxed (starting
position is the east quadrant and the platform is located
in the west quadrant).
Water maze cued learning. During testing, the water
maze tub was ﬁlled with tepid water (22 ± 2 C) and
made opaque by the addition of powdered milk. The
pool was divided into four quadrants of equal surface
area and the starting locations for testing were assigned
north, south, east, and west (not actual compass
positions but rather relative to the behavioral testing
room). The behavioral testing walls were already
painted white so just the other distal (to the water maze)
visual cues in the rooms were removed during the
actual testing. The cued spatial learning and memory
(acquisition and recall) task is sensitive to hippocampal
dysfunction (Morris, 2003; Winocur et al., 2006). During
the actual testing, a 10-cm diameter ﬂower pot
positioned in one quadrant halfway between the center
and the side of the pool and submerged 2 cm below the
surface with a small brass rod mounted on it vertically
protruding 10 cm above the water with a red plastic ball
mounted at the top served as a visual cue. Testing was
conducted the day after completion of the habituation
training, wherein the rats received 3 trials/day for four
consecutive days and the starting location and visual
goal positions were changed randomly for every trial.
During the trials, swim latency (time to reach the
platform) to reach the platform was recorded by a video
camera connected to an image analyzer (Water Maze
System Version 4.20, Columbus, OH, USA). In addition,
swimming speed (path length/swim latency) was used to
assess the motoric activity in performing the task.
Water maze discrimination learning task. The rats
were tested in the discrimination-learning test after two
days of rest following the cued learning and memory
task. The discrimination-learning task is sensitive to
non-hippocampal dysfunction (Winocur and Hasher,
2004; Macleod et al., 2007). Rats were given two trials
per day  4 days and had to discriminate between black
and white visible goals to ﬁnd the hidden platform and
RE
TRall extra-maze cues in the room were again covered.
The goal painted black was placed on top of the hidden
platform to provide escape (P+) from the water (located
in the southeast quadrant); whereas the other one
painted white was ﬂoating (P) and not able to oﬀer
suﬃcient buoyancy to support the rat (located in the
southwest quadrant). Both visible goals were placed
10 cm above the water level. For this task, path taken to
reach the correct goal was recorded as well as search
errors based on the choices of P+ compared to P
since the aim was to train the rats to avoid P. Search
errors represent the number of P choices made during
the daily trials.
TE
DTissue preparation
All rats were euthanized using CO2 asphyxiation and
cervical dislocation after completion of the behavioral
testing, the brains were quickly removed, and both
hippocampi manually dissected then processed.
Cervical dislocation was used to control for the eﬀects
of anesthesia-mediated tau phosphorylation (Planel
et al., 2007). Western blot was used for determination of
tau phosphorylation, and adenosine monophosphate-
activated protein kinase level. Biochemical assays were
used to determine the levels of oxidized glutathione
(GSH) and glutathione disulﬁde (GSSG, reduced
glutathione), activity of superoxide dismutase, overall
levels of reactive oxygen species (ROS), ADP/ATP
ratio, and PP2A activity.
CDetection of plasma vitamin D and calcium levels
Plasma levels of activated vitamin D (1, a25-
dihydroxyvitamin D3) were determined using the
commercially available ELISA assay (Immunodiagnostic
Systems, Fountain Hills, AZ, USA) according to
manufacturer’s instructions. After CO2 asphyxiation, the
thoracic cavity was opened and blood collected from
cardiac puncture was placed in EDTA-coated tubes.
Samples were centrifuged (6000g for 15 min at 4 C) and
stored at 80 C until assaying. Brieﬂy, controls and
samples were delipidated and transferred to supplied
immunocapsules containing monoclonal antibody to 1,
a25-dihydroxyvitamin D3 in suspension with vitamin D-
binding protein inhibitor for immunoextraction. After
eluting calcidiol from the immunocapsule gel, samples
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Awere evaporated in borosilicate glass tubes in a heating
block for 30 min under nitrogen gas ﬂow. Evaporated
samples were reconstituted in assay buﬀer and incubated
overnight with 100 ll of primary antibody solution.
Standards, controls, and samples were then pipetted into
a 96-well plate precoated with antibodies speciﬁc for 1,
a25-dihydroxyvitamin D3 then incubated at room
temperature for 90 min on an orbital plate shaker. After
several washes, the chromogen was added to each well
and incubated for an additional 30 min. Color reaction
was stopped by an equal volume of stop solution and
reaction was read in a microplate reader (Bio-Tek,
Winooski, VT, USA) at a wavelength of 450 nm (650-nm
reference wavelength). The color change for each sample
was plotted and measured within the range of the
standard curve. Assays were sensitive to 2.5 pg/ml and
coeﬃcient of variation was <10%.
For detection of calcium level, blood was also
collected from cardiac puncture during euthanasia using
syringes containing Ca2+-balanced heparin (Radiometer
America, Westlake, OH, USA) for ionized calcium and
immediately analyzed. Ionized calcium level and pH
were measured using the I-Stat Clinical Analyzer
(Abbott Laboratories, Princeton, NJ, USA). We
measured plasma levels of ionized calcium because this
is the active form of Ca2+. To determine ionized Ca2+
levels, we adjusted the actual values obtained to a pH
of 7.4 since acidosis can aﬀect calcium binding.
Western blot
Levels of adenosine monophosphate-activated protein
kinase (AMPK) were assessed using 0.4 g of
hippocampal tissue from each rat that was
homogenized and centrifuged at 25,000g for 20 min as
previously described (Briones et al., 2006, 2009).
Aliquots from the supernatant were removed for protein
determination. Protein concentration in samples was
determined using the BCA-Protein assay (Pierce,
Rockford, IL, USA).
For assessment of insoluble tau phosphorylation,
0.3 g of hippocampal tissue from each rat was
homogenized as previously described (Briones et al.,
2006, 2009) then centrifuged at 14,000g for 10 min at
4 C. The supernatant was collected from this low-speed
spin then incubated in 1% RIPA buﬀer (50 mM Tris,
150 mM NaCl, 1% NP-40, 5 mM EDTA, 0.5% sodium
deoxycholate, and 0.1% SDS, pH 8.0) for 10 min
followed by ultracentrifugation at 200,000g at room
temperature. The pellets were resuspended in 450 ll of
homogenizing buﬀer then ultracentrifuged at 200,000g
for 30 min at room temperature. The supernatant was
removed and the pellet was resuspended again in
200 ll 1 Laemmli sample buﬀer (Sigma–Aldrich, St.
Louis, MO, USA) then centrifuged at 14,000g for 10 min
at 4 C to obtain the ﬁnal insoluble sample.
For Western blot analyses, equal amounts of protein
(40 lg) from each rat were loaded and separated
by SDS–PAGE gel electrophoresis as previously
described (Briones et al., 2009). The protein bands
were electrophoretically transferred to nitrocellulose
membranes (Amersham, Piscataway, NJ, USA) stained
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TRwith 0.5% Ponceau Red to visualize total proteins, then
destained. Non-speciﬁc binding sites were blocked then
nitrocellulose membranes were incubated overnight at
4 C with gentle agitation in the primary antibody. The
primary antibodies used were: (1) anti-tau (mouse
monoclonal, 1:1500; clone S.125.0); (2) anti-
phosphorylated tau, Ser404 (rabbit polyclonal, 1:2000); (3)
anti-phosphorylated tau, Ser214 (mouse monoclonal,
1:2000; clone AT100); (4) anti-phosphorylated tau Thr231
(mouse monoclonal, 1:1000; clone AT180); (5) anti-
AMPK (rabbit polyclonal, 1:1000; Santa Cruz
Biotechnology, Santa Cruz, CA, USA); (6) anti-
phosphorylated AMPK (polyclonal rabbit, 1:1000; Santa
Cruz Biotechnology); and (7) anti-b-actin (rabbit
polyclonal, 1:2000; Santa Cruz Biotechnology). All tau
antibodies were obtained from Thermo Scientiﬁc
(Rockford, IL, USA). The secondary antibodies used
were horseradish peroxidase-conjugated immunoglobulin
(Sigma) and the Super Signal chemiluminescense
substrate kit (Pierce) was used to visualize
immunoreactive bands. After visualization, the
membranes were then stained with Amido-Black to
qualitatively verify protein loading. A series of dilutions
were performed and immunoblotted for each antibody to
establish that the relationship between protein band and
intensity was linear over the range of band intensities
observed in the samples. Band visualization was
obtained by exposure of membranes to autoradiographic
ﬁlm (Kodak Biomax). Samples were analyzed in
quadruplicates and measurements were averaged and
used as one individual data point for statistical analysis.
Quantiﬁcation of diﬀerences in protein bands between
samples was done using densitometric analysis (Scion
Image Beta 4.0.2; Frederick MD). The internal control
b-actin was used to standardize experimental values in
densitometric analysis.
Biochemical assays
Levels of ROS, activity of superoxide dismutase (SOD),
glutathione level (both reduced and oxidized forms),
ADP/ATP ratio, and PP2A activity were evaluated using
diﬀerent biochemical assays and these data provided
information on brain energy metabolism, redox state,
and phosphatase activity. For determination of SOD
activity and levels of ROS, 0.3 g of hippocampal tissue
was homogenized in ice-cold phosphate buﬀer (0.1 M,
pH 7.4) containing KCl (140 mM), EDTA (1 mM) and the
protease inhibitor phenylmethylsulfonyl ﬂuoride (1 mM)
using a Teﬂon-glass homogenizer. The homogenate
was centrifuged at 960g for 10 min and the supernatant
was collected.
Determination of ROS level. The ROS and nitrogen
reactive species (RNS) production was assessed
through the 20,70-dichloroﬂuorescein (20,70-DCF)
oxidation method (Lebel et al., 1992). Brieﬂy, 60 lL of
the tissue sample was incubated at 37 C in the dark
with 240 lL of 20,70-DCF diacetate (H2DCFDA) reagent
(Invitrogen, Carlsbad, CA, USA) in a 96-well plate.
H2DCFDA is cleaved by cellular esterases and form
H2DCF that is oxidized by ROS and RNS that are
CT
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Apresent in the sample, producing the ﬂuorescent
compound DCF. DCF oxidation was measured using a
microplate reader at 488-nm excitation and 525-nm
emission wavelength. A standard curve, using standard
DCF (0.25–10 mM) was performed in parallel with the
samples. The ﬂuorescent intensity unit was normalized
with the protein content, plotted and measured against
the standard curve, and expressed in relative unit
production per minute.
Determination of SOD activity. Total SOD activity was
evaluated at room temperature according to previously
described method (Misra and Fridovich, 1972).
Approximately 200 ll of hippocampal tissue
homogenate was added to 3 ml of EDTA – sodium
carbonate buﬀer (0.5 M) at pH 10.2. The reaction was
started by adding 100 ll of epinephrine (30 mM in 0.1 M
HCl) to the homogenate and SOD activity was
evaluated by quantifying the inhibition of superoxide-
dependent autoxidation of epinephrine and the
absorbance of the sample was veriﬁed using a
microplate reader at a wavelength of 480 nm. One unit
of SOD is deﬁned as the amount of enzyme that inhibits
the speed of oxidation of epinephrine by 50%. Results
were expressed as units/mg protein.
Determination of GSH andGSSG. To quantify levels of
glutathione, 0.3 g of hippocampal tissuewas homogenized
in a cold MES [0.4 M 2-(N-morpholino) ethanesulfonic acid
and 2 mM EDTA, pH 6.0] buﬀer (Sigma–Aldrich) then
centrifuged at 10,000g for 15 min at 4 C. Aliquots from
the supernatant were removed for protein determination.
Protein concentration in samples was determined using
the BCA-Protein assay (Pierce). The remaining
supernatant was deproteinated and stored at 20 C until
use. GSH level was measured using the glutathione
assay kit (Cayman Chemical, Ann Arbor, MI, USA)
according to the manufacturer’s instructions. Brieﬂy,
samples and standards (provided by the manufacturer)
were loaded in a 96-well plate and the Assay cocktail
(provided by the manufacturer) was added. GSSG was
also measured using the same procedure above but the
deproteinated samples were ﬁrst treated with 1 M 4-
vinylpyridine (Sigma, St. Louis, MO, USA). Color
absorbance was measured every 5 min for a total of
25 min using a microplate reader at a wavelength of
405 nm (650-nm reference wavelength). Values of GSH
and GSSG for each sample were normalized with the
protein content and calculated by plotting them against
the standard curve. The inter-assay and intra-assay
coeﬃcient of variation are 3.6% and 1.6%, respectively;
and the dynamic range of the assay kit for GSH and
GSSG are 0–16 lM and 0–8 lM, respectively.
Determination of ADP/ATP ratio. To evaluate brain
metabolism, the ApoSENSOR ADP/ATP
Bioluminescence Assay kit was used and the procedure
was carried out according to the manufacturer’s
speciﬁcations (BioVision Inc., Milpitas, CA, USA).
Approximately, 0.3 g of hippocampal tissue from each
rat was homogenized in cold PBS buﬀer then 100 ll of
RE
TRNucleotide Releasing buﬀer was added to the sample.
ATP level was measured by adding 1 ll of ATP
Monitoring enzyme to the prepared sample then the
color reaction was read after 1 min using the microplate
reader at a wavelength of 450 nm (650-nm reference
wavelength). The color change was proportional to the
total level of ATP. To the same sample, 1 ll of ADP-
Converting Enzyme was added then the color reaction
was read again after 10 min to yield ADP data then
another reading was done after 1 min. Data were
normalized with the protein content and ADP/ATP ratio
was then calculated as: ADP values (data from second
reading  data from ﬁrst reading)/ATP values.
Measurement of PP2A. The PP2A Immunoprecipitation
Phosphatase BioAssay Kit (Millipore, Temecula, CA, USA)
was used according to the manufacturer instructions to
determine PP2A activity. Brieﬂy, 0.3 g of hippocampal
tissue was homogenized in 40 volume/weight of 20 mM
imidazole–HCl pH 7.0, 2 mM EDTA, 2 mM EGTA, 1 mM
phenylmethanesulfonylﬂuoride (PMSF), 10 ll/ml of
Protease Inhibitor Cocktail P8340 (Sigma–Aldrich), and
centrifuged at 2000g for 5 min at 4 C. After determination
of protein concentration, the PP2A catalytic subunit
was immunoprecipitated with a monoclonal antibody
and protein A agarose then the activity of the immuno-
precipitated PP2A was assessed by the release of
phosphate from threonine phosphopeptide over a period of
10 min at 30 C. The amount of phosphate released was
measured by the absorbance of the molybdate-malachite
green phosphate solution at 630 nm using a microplate
reader and ﬂuorescent intensity was normalized with the
protein content.
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The SAS general linear model (SAS Institute, North
Carolina) procedures for two-way analysis of variance
(ANOVA) were used to examine eﬀects of experimental
conditions (vitamin D vs. saline groups) and age (young
vs. aged) on the dependent variables. Two-way
repeated measures ANOVA was used to examine
vitamin D supplementation eﬀects on behavioral
performance on the water maze to determine
diﬀerences in swim latency, path length, search errors,
and swimming speed. When appropriate, the SAS
CONTRAST statement was used for planned
comparisons of the eﬀects of supplementation (vitamin
D vs. saline groups) and age (young and aged), and the
combination of age and supplementation. All error bars
represent ± standard error of the mean (SEM) of the
sample size used in the study. In addition, regression
analysis was performed to examine the relationship
between brain energy metabolism and behavioral
performance.RESULTS
Plasma levels of vitamin D and calcium
To determine age-related vitamin D changeswemeasured
circulating levels of its active form, 1,a25-dihydroxyvitamin
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(F(3,36) = 9.33, p< 0.05) when compared to the young
animals (Fig. 2A); but the deﬁciency seen in the aged rats
that received the supplementation was signiﬁcantly less
in comparison to the aged CON animals
(F(3,36) = 10.02, p< 0.05). Post hoc comparisons
showed a signiﬁcant 1, a25-dihydroxyvitamin D3
deﬁciency in the aged CON rats to less than 26% of the
young CON group suggesting an age-related vitamin D
deﬁciency. Further analysis revealed circulating levels of
1, a25-dihydroxyvitamin D3 is 22% less in the aged CON
rats compared to the aged animals that received the
supplementation. No signiﬁcant diﬀerences were evident
in circulating levels of 1, a25-dihydroxyvitamin D3 in the
young animal groups.
Measurement of ionized calcium showed age-related
signiﬁcant decrease (F(3,36) = 10.19, p< 0.05) in
plasma levels (Fig. 2B). However, supplementation with
vitamin D in the aged rats modulated the reduction in
plasma levels of ionized calcium (F(3,36) = 9.83,
p< 0.05). That is, ionized calcium level in the aged
CON group is 35% lower than that of the aged vit D
animals. Post hoc comparisons showed no signiﬁcant
diﬀerence in ionized calcium in the young animal group.
Together, these results suggest an age-related
deﬁciency in vitamin D metabolism accompanied by a
decrease in ionized calcium but giving supplementation-
modulated hypovitaminosis D and minimized the
reduction in calcium. These results are hardly surprising
since vitamin D is essential for maintaining calcium
homeostasis (Dusso, 2013). A
Vitamin D mitigates age-related cognitive decline in
the water maze tasks
Rats were tested in the water maze for cued learning and
memory as well as the discrimination learning tasks. In
the cued learning and memory task, within-subjects
eﬀect was seen for swim latency across the test days
given that all rats learned to perform the task over the
four testing days. An overall signiﬁcant main eﬀect of
age was seen in mean swim latency (Fig. 3A) and the
aged CON group demonstrated longer mean swim
latency overall compared to all groups (F(3,36) = 8.19,
p< 0.05). Meanwhile, a signiﬁcant main eﬀect of
ET
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calcium (B) in the aged rats when compared to the young animals. But post ho
deﬁciencies. ⁄p< 0.05, ⁄⁄p< 0.01. Legends: CON – control; vit D – vitamin
Rvitamin D (F(3,36) = 8.42, p< 0.05) was also seen in
that the aged rats that received the supplementation
demonstrated a decrease in mean swim latency
compared to the aged CON group. Although the aged
vit D group performed signiﬁcantly better when
compared to the aged CON rats, they still demonstrated
impairment in comparison to the young animal groups.
No signiﬁcant eﬀects of age on swimming speed was
seen (F(3,36) = 5.67, p= 0.07). No signiﬁcant
diﬀerence was seen in mean swim latency between the
young animal groups. Additionally, no interaction eﬀect
was seen between age and vitamin D in mean swim
latency.
Measurement of path taken to reach the goal (path
length) in the discrimination learning task showed
within-subjects eﬀect (Fig. 3B) where all rats showed a
continuous decrease in the swimming distance covered
to reach the platform across the test days. Overall
signiﬁcant main eﬀects of age (F(3,36) = 9.31,
p< 0.05) and vitamin D (F(3,36) = 8.93, p< 0.05)
were seen where the aged CON animals often took the
path to the incorrect goal compared to all groups
while the aged vit D group performed better but still
showed impairment in comparison to the young
animals. No signiﬁcant diﬀerence was seen when the
young animal groups were compared. No signiﬁcant
interaction eﬀect (p= 0.10) was seen between age
and vitamin D in mean path length. Analysis of the
number of errors made by the rats in locating the
correct goal showed an overall signiﬁcant main eﬀect
of age (F(3,36) = 9.01, p< 0.05) and vitamin D
(F(3,36) = 8.39, p< 0.05) where aged CON rats
regularly chose P (the incorrect goal) in most of the
trials. Meanwhile, aged rats that received the vitamin D
supplementation committed less error but their
performance is still signiﬁcantly impaired in comparison
to the young animals (Fig. 3C). On the contrary, no
signiﬁcant diﬀerences were seen in performance of the
young CON and young vit D groups in discerning the
correct goal. In addition, no signiﬁcant interaction eﬀect
was seen between age and vitamin D (p= 0.08).
Together, these data suggest that age can result in the
impairment of complex cognitive task but providing
vitamin D supplementation may slow down this
cognitive decline.
CT
EDiﬁcant deﬁciency in plasma circulating levels of both vitamin D (A) and
c comparisons show that supplementation of vitamin D mitigated both
D supplementation group; ANOVA – analysis of variance.
Fig. 3. Behavioral testing. Two-ANOVA with repeated measures show that aged rats have signiﬁcantly longer mean swim latency in the cued
learning and memory task (A) in comparison to the young animals. Post hoc comparisons show that the aged CON group has the greatest deﬁcit.
Analysis of performance in the discrimination learning task using 2-way ANOVA with repeated measures also show that aged rats took signiﬁcantly
longer paths to reach the goal (B) and made signiﬁcantly more errors in discriminating between the correct and incorrect goals (C) compared to the
young animal groups. Post hoc comparisons show that age-related performance deﬁcits are attenuated in the vit D group. ⁄p< 0.05 – signiﬁcantly
diﬀerent from the young animal groups, ⁄⁄p< 0.01 – signiﬁcantly diﬀerent from all groups. Legends: CON – control; vit D – vitamin D
supplementation group; ANOVA – analysis of variance.
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We measured total AMPK and phosphorylated AMPK
(pAMPK) to obtain the pAMPK/AMPK ratio as an
indication of cellular energy status (Fryer et al., 2002;
Kleman et al., 2008). No signiﬁcant group diﬀerences
were seen in total AMPK level (Fig. 4A). However,
analysis of pAMPK showed signiﬁcant main eﬀects of
both age (F(3,36) = 11.09, p< 0.05) and vitamin D
(F(3,36) = 10.88, p< 0.05) where aged rats showed
signiﬁcantly decrease pAMPK in comparison to the
young animal groups (Fig. 4B). But providing vitamin D
supplementation to the aged rats signiﬁcantly increased
pAMPK levels by 27% compared to the aged CON
group. Post hoc comparison showed that although the
pAMPK levels of aged rats that received vitamin D are
higher than the aged CON group, it was still signiﬁcantly
lower by 20% and 23% in relation to the young CON
and young vitamin D rats, respectively. Comparison of
the young rat groups did not show any signiﬁcant
diﬀerence on pAMPK.
When the pAMPK/AMPK ratio was quantiﬁed,
signiﬁcant main eﬀects of both age (F(3,36) = 11.29,
p< 0.05) and vitamin D (F(3,36) = 10.84, p< 0.05)
were also seen in that aged rats showed a signiﬁcantly
decreased pAMPK/AMPK ratio in comparison to the
young animal groups (Fig. 4C). Post hoc comparisons
showed that pAMPK/AMPK ratio in the aged rats given
vitamin D supplementation was 24% higher compared to
the aged CON. However, the pAMPK/AMPK level of
aged rats that received vitamin D was still 19% and
24% lower when compared to the young CON and
RE
TRyoung vitamin D rat groups, respectively. Comparison of
the young rat groups did not show any signiﬁcant
diﬀerence on pAMPK/AMPK ratio.
Analysis of ADP/ATP ratio to determine brain
metabolism also showed signiﬁcant main eﬀects of both
age (F(3,36) = 10.22, p< 0.05) and vitamin D
(F(3,36) = 9.13, p< 0.05) in that aged rats had a
signiﬁcantly increased ADP/ATP ratio in comparison to
the young animal groups (Fig. 4D). Post hoc
comparisons showed that aged rats given vitamin D
supplementation had 22% lower ADP/ATP ratio
compared to the aged CON. However, the ADP/ATP
ratio of aged rats that received vitamin D was still 27%
and 21% higher compared to the young CON rats and
the young vitamin D group, respectively. Comparison of
the young rats did not show any signiﬁcant group
diﬀerence on ADP/ATP ratio. A signiﬁcant positive
relationship (r2 = .82, p< 0.05) was also seen between
ADP/ATP ratio and the number of errors committed on
the last day of behavioral testing (Fig. 4E). Together
these results suggest that the capacity to maintain
energy metabolism is compromised in aging but using
vitamin D supplementation can diminish the eﬀects of
age on energy metabolism. Our results also suggest
that decreased in ATP supply possibly contributed to
age-related cognitive decline.
Vitamin modulates age-related changes in redox
state
We measured ROS level, activity of the enzymatic
antioxidant SOD, and level of the antioxidant glutathione
Fig. 4. Indicators of brain energy metabolism. Two-way ANOVA shows no signiﬁcant group diﬀerences in the total AMPK levels (A) but the level of
phosphorylated AMPK (B) and ratio of pAMPK/AMPK (C) are signiﬁcantly decreased in the aged rats compared to the young animals. Post hoc
comparisons show that providing vitamin D supplementation is able to mitigate the age-related decrease in pAMPK and pAMPK/AMPK ratio.
Representative Western blots of total AMPK and pAMPK are shown on the right upper panel. Two-way ANOVA also shows signiﬁcant age-related
increased in ADP/ATP ratio (D) and post hoc comparisons show that giving vitamin D supplementation diminished the eﬀects of aging on ADP/ATP
ratio. Linear regression also shows that in the aged rat groups increased ADP/ATP ratio is signiﬁcantly related to increased number of errors made
on the last day of behavioral testing (E). ⁄p< 0.05, ⁄⁄p< 0.01. Legends: 1 – aged control; 2 – aged vitamin D; 3 – young control; 4 – young vitamin
D; CON – control; vit D – vitamin D supplementation group; ANOVA – analysis of variance.
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showed a signiﬁcant main eﬀect of age (F(3,36) = 9.20,
p< 0.05) and vitamin D (F(3,36) = 8.92, p< 0.05) in
that increased dichloroﬂuorescein expression was seen
in the aged rats when compared to the young animals
(Fig. 5A). Post hoc comparison showed that providing
vitamin D supplementation signiﬁcantly decreased the
expression of dichloroﬂuorescein in the hippocampus of
aged rats by 21% in relation to the aged CON group.
However, providing vitamin D to the young animals did
not produce any signiﬁcant eﬀect in dichloroﬂuorescein
expression. When total SOD activity was measured, our
results also showed a signiﬁcant main eﬀect of age
(F(3,36) = 8.06, p< 0.05) and vitamin D
(F(3,36) = 8.89, p< 0.05) where decreased SOD
activity was seen in the aged rats compared to the
young animals but this age-related decreased in
antioxidant enzyme activity was modulated by vitamin D
supplementation by 21% (Fig. 5B). Meanwhile, no
signiﬁcant vitamin D eﬀect was seen in SOD activity in
the young animals.
We also measured GSH and GSSG levels and
signiﬁcant main eﬀects of age and vitamin D were seen.
Levels of the reduced form of glutathione (GSH) were
signiﬁcantly decreased in the aged rats
(F(3,36) = 10.16, p< 0.05) but levels of the oxidized
form (GSSG) were signiﬁcantly increased
(F(3,36) = 9.43, p< 0.05). However, giving vitamin D
supplementation mitigated and age-related changes in
GSH (F(3,36) = 8.17, p< 0.05) and GSSG
(F(3,36) = 7.94, p< 0.05) levels (Fig. 5C, D). When
GSH/GSSG ratio was analyzed, we found signiﬁcantly
lower values in the aged rats (F(3,36) = 10.44,
p< 0.05) compared to the young animals (Fig. 5E).
Conversely, providing vitamin D supplementation to the
aged rats moderated the reduction in GSH/GSSG ratio
RE
TRby 39%. Comparison of the young animal groups
showed no signiﬁcant diﬀerence in GSG and GSSH
levels, as well as GSH/GSSG ratio. These results
suggest an age-related imbalance in redox state exists
but giving vitamin D supplementation modulated this
imbalance.
C
Vitamin D mitigates age-related tau hyperphosphory-
lation by enhancing phosphatase activity
Next we examined changes in tau phosphorylation in the
hippocampus associated with aging and vitamin D
supplementation. Using Western blot, we used three
antibodies targeting several key tau phosphoepitopes.
The phosphorylated tau antibodies detected pre-
neuroﬁbrillary tangle phospho-tau protein (pThr231),
intraneuronal neuroﬁbrillary tangle phospho-tau protein
(pSer214), and extracellular neuroﬁbrillary tangle
phospho-tau protein (pSer404) according to earlier
studies (Augustinack et al., 2002; Cui et al., 2012). Our
results showed no signiﬁcant group diﬀerences in total
tau levels (F(3,36) = 5.05, p= 0.11) but a signiﬁcant
increased in hippocampal tau phosphorylation at the
pre-tangle (F(3,36) = 9.75, p< 0.05), intraneuronal
tangle (F(3,36) = 9.59, p< 0.05), and extracellular
tangle sites (F(3,36) = 10.02, p<0.05) were seen in the
aged rats compared to the young animals (Fig. 6A–C).
However, vitamin D supplementation signiﬁcantly
modulated age-related tau hyperphosphorylation at the
pre-tangle, intraneuronal tangle, and extracellular tangle
sites by 33%, 37%, and 31%, respectively. No
signiﬁcant increase in tau phosphorylation was seen in
the young animal groups.
We also evaluated PP2A activity and found it to be
signiﬁcantly decreased (F(3,36) = 9.43, p< 0.05) in
the aged group (Fig. 7A). However, administration of
Fig. 5. Indicators of redox state. Two-way ANOVA was used to analyze redox state and post hoc comparisons were done using the SAS Contrast
statements. Level of ROS is signiﬁcantly increased (A) while activity of SOD is signiﬁcantly decreased (B) in the aged rats in comparison to the
young animals. As well, level of GSH is signiﬁcantly decreased (C) but GSSG level (D) is signiﬁcantly increased in the aged rats compared to the
young animals. Accordingly, an age-related decreased in GSH/GSSG ratio (E) is seen. Nevertheless, giving vitamin D supplement modulated the
age-related changes in redox state. ⁄p< 0.05, ⁄⁄p< 0.01. Legends: CON – control; vit D – vitamin D supplementation group; ANOVA – analysis of
variance.
T. L. Briones, H. Darwish /Neuroscience 262 (2014) 143–155 151
A
TE
Dvitamin D in the aged rats enhanced PP2A activity by
29%. PP2A subunit B examined in this study is an
important serine and threonine phosphatase that plays a
critical role in central nervous system function (Liu and
Wang, 2009) and our data demonstrating decreased
PP2A and increased tau phosphorylation in the aged
animals given vitamin D compared to the aged control
rats suggest that the supplementation was able to
modulate age-related tau hyperphosphorylation through
PP2A actions. These results suggest that providing
vitamin D supplements in aged rats was able to regulate
tau hyperphosphorylation by upregulating PP2A activity.
RT
DISCUSSION
In the present study we demonstrate that age-related
vitamin D deﬁciency is associated with tau
hyperphosphorylation, decreased brain energy
metabolism and PP2A activity, and reduced redox state
in the hippocampus and that these neuropathological
processes are accompanied by cognitive decline. To our
knowledge this is the ﬁrst study to link the eﬀects of
vitamin D on tau phosphorylation and brain energy
metabolism in the normal aging brain. Aging is
associated with declines in energy production in the
brain as well as parallel changes in redox status with a
pro-oxidant shift that may be due in part through the
mitochondrial generation of superoxide radical and
hydrogen peroxide (Boveris and Navarro, 2008; Yin
et al., 2012a).
Here we show that energy homeostasis is altered in
the aging hippocampus evidenced by decrease pAMPK/
AMPK ratio as well as an increased ADP/ATP ratio. Our
data are in line with previous reports on decreased
REAMPK activity and/or decreased responsiveness to
AMPK activity in diﬀerent tissues as a function of age
(Greer et al., 2007; Yap et al., 2009). AMPK is regarded
as a central sensor of cellular energy status or a
metabolic fuel gauge conserved along the evolutionary
scale in eukaryotes that senses changes in the
intracellular AMP/ATP ratio (Kahn et al., 2005).
Activation or phosphorylation of AMPK maintains
cellular energy stores, switching on catabolic pathways
that produce ATP, mostly by enhancing oxidative
metabolism and mitochondrial biogenesis, while
switching oﬀ anabolic pathways that consume ATP
(Kahn et al., 2005). The notion of age-related decline in
energy status seen in the present study is in line with
previous reports on the gradual decline in brain energy
metabolism during aging (Navarro and Boveris, 2007;
Boveris and Navarro, 2008).
Our data also show an increased ADP/ATP ratio in the
aged rats suggesting that the ATP-generating capacity of
the aging brain is diminished possibly leading to a lower
ability to maintain energy supply. The decline in energy
metabolism during aging increases the brain’s
susceptibility to neurodegenerative disorders (Atamna
and Frey, 2007; Gibson et al., 2010), and the decreased
ability to maintain ATP supply most likely contributes to
age-related cognitive impairment since it will be diﬃcult
to adapt to the high demands imposed by energy-
consuming brain activity such as learning and memory.
Indeed, our data show a signiﬁcant relationship
between ADP/ATP ratio and performance on the last
day of behavioral testing in the learning and memory
task. Age-related decrease in brain energy homeostasis
can also potentially lead to the disruption in the redox
state.
C
Fig. 6. Tau Phosphorylation in the Hippocampus. Upper panel left: representative Western blots of total tau and tau phosphorylation at diﬀerent
sites. Two-way ANOVA shows signiﬁcantly increase tau phosphorylation at the pre-neuroﬁbrillary tangle (pThr231), intraneuronal neuroﬁbrillary
tangle (pSer214), and extracellular neuroﬁbrillary tangle (pSer404) sites (A–C) in the aged rats compared to the young animals. Post hoc comparisons
show that providing vitamin D supplementation tempered the age-related hyperphophorylation of the tau protein. ⁄p< 0.05, ⁄⁄p< 0.01. Legends: 1
– aged control; 2 – aged vitamin D; 3 – young control; 4 – young vitamin D; CON – control; vit D – vitamin D supplementation group; ANOVA –
analysis of variance.
Fig. 7. Protein phosphatase 2A (PP2A) activity. Two-way ANOVA
shows that PP2A activity is signiﬁcantly decreased in the aged rats in
comparison to the young animals (A). But post hoc comparisons
show that giving vitamin D supplement modulated the age-related
decreased in PP2A activity. ⁄p< 0.05. Legends: CON – control; vit D
– vitamin D supplementation group; ANOVA – analysis of variance.
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shown as (i) increased ROS level, (ii) lower levels of
reduced glutathione, increased levels of oxidized
glutathione, and decreased GSH/GSSG ratio, and (iii)
decreased activity of the SOD enzymatic antioxidant,
when compared to the young animals and these dataare consistent with the free radical theory of aging
(Harman, 1992). The increased ROS level seen in the
present study is consistent with previous reports
showing age-related upregulation in free radical
production resulting in higher susceptibility for oxidative
stress (Calabrese et al., 2010; Nunomura et al., 2012;
Flynn and Melov, 2013). The beneﬁcial eﬀects of
vitamin D on regulating age-related changes in redox
homeostasis are shown in our data on decreased ROS
level, and increased SOD activity and glutathione levels
in the aged rats given the supplementation. SOD as an
enzymatic antioxidant is responsible for converting the
ROS superoxide radical to hydrogen peroxide so that it
can be eliminated by glutathione peroxidase (Hu et al.,
2009). Here we measured both the reduced and
oxidized forms of glutathione instead of the glutathione
enzymatic antioxidant.
Glutathione, a potent antioxidant, is present in the cell
in reduced (GSH) and oxidized (GSSG) forms and acts as
a redox buﬀer especially in the brain (Dringen and
Hirrlinger, 2003). The reduced GSH serves as a
substrate for enzymes that scavenge ROS with the
concomitant production of oxidized GSSG; and the
oxidized GSSG is recycled back to GSH (Dringen and
Hamprecht, 1998). Thus, the GSH/GSSG coupling acts
to maintain the redox environment of the cell promoting
survival. It stands to reason then that the dysregulation
of GSH/GSSG homeostasis can potentially contribute to
the vulnerability, initiation, and progression of
neurodegeneration (Fukui and Moraes, 2008; Johnson
et al., 2012).
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development of neurodegenerative disorder because of
disruption in redox homeostasis is supported in this
study as our data show that age-related increased in
ROS levels, decreased SOD activity, and GSH/GSSG
ratio are accompanied by a concomitant increased in
the phophorylation of the tau protein. Tau is a major
microtubule-associated protein that plays a large role
in the outgrowth of neuronal processes and the
development of neuronal polarity (Gotz et al., 2013).
Tau promotes microtubule assembly and stability, and
is abundantly present in the neuronal axons of the
central nervous system. However, recent studies
show that tau is also expressed in glial cells (Fuster-
Matanzo et al., 2012). The phosphorylation of tau
regulates microtubule binding and assembly but
hyperphosphorylation destabilizes microtubules by
decreased binding of tau to microtubules (Hashiguchi
and Hashiguchi, 2013), resulting in aggregation of the
protein leading to the formation of neuroﬁbrillary
tangles (Gotz et al., 2013), a pathological feature in
most neurodegenerative diseases, especially
Alzheimer’s disease. In the present study, we detected
signiﬁcantly increased tau phosphorylation at the pre-
tangle (phosphorylation at thr231), intraneuronal tangle
(phosphorylation at ser214), and extracellular tangle
(phosphorylation at ser404) sites in the hippocampus of
aged rats; and these data are consistent with previous
reports on age-related increase in the phosphorylation
of the tau protein (Schmitt et al., 2012; Ramcharitar
et al., 2013). However, our study is the ﬁrst to show
that providing vitamin D supplementation signiﬁcantly
limited the age-related hyperphosphorylation of tau
proteins suggesting a usefulness of this neurohormone
in decreasing the risk for neuroﬁbrillary tangle formation.
The mechanism whereby vitamin D regulates age-
related changes in tau hyperphosphorylation in this
study is most likely related to its ability to modulate
PP2A activity. Although the brain has several protein
phosphatases, PP2A make up more than 70% of the
serine/threonine phosphatase activity in mammalian
cells (Liu et al., 2005). The phosphorylation of tau that
suppresses its microtubule binding and assembly
activities in adult mammalian brain is primarily
regulated by PP2A and not by PP2B (Liu et al., 2005;
Liu and Gotz, 2013); and PP2A also regulates the
activities of several tau kinases in the brain (Liu and
Gotz, 2013). Our data on increased tau
phosphorylation and decreased PP2A activity are
hardly surprising because of reports that show: (1)
transient decrease in PP2A activity in the presence of
anesthesia and hypothermia induced by anesthesia
results in reversible abnormal tau hyperphosphorylation
in the normal brain (Planel et al., 2007); and (2) non-
transient decrease in PP2A activity in Alzheimer’s brain
correlates with irreversible abnormal tau hyperphosph-
orylation (Iqbal et al., 2009).
Collectively, the age-related biological changes in
tau, energy metabolism, and redox state seen in the
current study is associated with cognitive decline,
which is not surprising since studies show that
RE
TRoxidative stress resulting from a decline in energy
metabolism and tau hyperphosphorylation coincide with
the onset of cognitive impairment (Federico et al.,
2012). Our data show that impairment in cognitive
function is manifested in tasks that involve both
hippocampal and non-hippocampal function. But a key
ﬁnding in this study is that providing vitamin D
supplementation mitigates the age-related behavioral
changes. Vitamin D is an important hormone with well-
characterized eﬀects in the whole body system in early
life as well as in later life (DeLuca et al., 2013). It is
highly likely that vitamin D is able to regulate age-
related cognitive decline because of its role in: (1)
regulating cellular function, and (2) binding to the
molecules of the endogenous antioxidant systems
resulting in the neutralization of oxygen molecules
before they can harm cells as free radicals, and thus
protects cells against oxidative stress (reviewed in
Chung et al., 2006). Studies show that vitamin D is a
cellular regulator via its actions on signal transduction
and because of this it is possible that this hormone is
able to modulate neuronal function thereby minimizing
their energy needs (Eyles et al., 2003, 2007).
In the past decades, our knowledge about vitamin D
and its biological activity has signiﬁcantly improved.
Reports on vitamin D deﬁciency in the elderly (Coudray
et al., 2005; Annweiler et al., 2010, 2012) is extended in
the present study where we show that aged animals are
deﬁcient in the active form of vitamin D, 1, a25-
dihydroxyvitamin D3. The age-related deﬁciency in
vitamin D demonstrated here may be due to a decrease
in production and/or an increase in metabolic clearance
rate because of the high levels of 24-hydroxylase, an
enzyme that metabolizes vitamin D, seen in the elderly
(reviewed in (Tuohimaa et al., 2009). The lack of
signiﬁcant diﬀerence in circulating levels of 1, a25-
dihydroxyvitamin D3 in the young animals is hard to
explain but it may be that the amount of supplement
used in the present study is not suﬃcient to cause an
increase in plasma levels in conditions where no
deﬁciency exist.
A surprising ﬁnding in this study is that vitamin D
supplementation was only able to modulate age-
related biological and behavior changes and not
totally overcome the eﬀects of age on tau
phosphorylation, brain energy metabolism, disruption
in redox state, and cognitive function. It is possible
that due to the complexity of brain function, there is
no single ‘‘anti-aging therapy’’ that truly reverses the
eﬀects of the aging process. Although this study does
not prove a causal relationship between vitamin D and
neurological function or vitamin D and tau
hyperphophorylation in aging, the data presented
suggest an immense potential for this neurohormone
to slow down age-related impairment in cognitive and
biological functioning. Given that neurodegeneration
and cognitive impairment are likely to play a central
role in the health care system and society in the near
future, use of vitamin D is an easy, inexpensive, and
safe way to modify the risk factors associated with
aging.
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